Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Colorcon
McKesson
Baxter
Dow

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

ESTRADIOL CYPIONATE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Estradiol Cypionate, and what generic alternatives are available?

Estradiol Cypionate is a drug marketed by Dr Reddys and is included in one NDA.

The generic ingredient in ESTRADIOL CYPIONATE is estradiol cypionate. There are seventy-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estradiol cypionate profile page.

Summary for ESTRADIOL CYPIONATE
Drug patent expirations by year for ESTRADIOL CYPIONATE
Recent Clinical Trials for ESTRADIOL CYPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Biolab Sanus FarmaceuticaPhase 1
Galeno Desenvolvimento de Pesquisas ClĂ­nicasPhase 1
Sidney Kimmel Comprehensive Cancer CenterPhase 2

See all ESTRADIOL CYPIONATE clinical trials

Synonyms for ESTRADIOL CYPIONATE
(17?)-3-Hydroxyestra-1,3,5(10)-trien-17-yl 3-cyclopentylpropanoate
(17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17.beta.-cyclopentanepropanoate
(17beta)-3-hydroxyestra-1(10),2,4-trien-17-yl 3-cyclopentylpropanoate
(1S,11S,14S,15S,10R)-5-hydroxy-15-methyltetracyclo[8.7.0.0<2,7>.0<11,15>]hepta deca-2,4,6-trien-14-yl 3-cyclopentylpropanoate
(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) 3-cyclopentylpropanoate
(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl 3-cyclopentylpropanoate
[(13S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
1,3,5(10)-Estratriene-3,17|A-diol 17-cyclopentylpropionate
1,3,5(10)-Estratriene-3,17beta-diol 17-cyclopentylpropionate
17.beta.-[(3-Cyclopentylpropanoyl)oxy]estra-1,3,5(10)-trien-3-ol
17.beta.-Estradiol 17-cyclopentylpropionate
17.beta.-Estradiol cyclopentanepropionate
17.beta.-Estradiol cyclopentylpropionate
17.beta.-Estradiol cypionate
17|A-Estradiol-17-cypionate
17beta-Estradiol 17-cyclopentylpropionate
17beta-Estradiol 17-cypionate
3-Hydroxyestra-1,3,5(10)-trien-17-yl 3-cyclopentylpropanoate
3-hydroxyestra-1(10),2,4-trien-17-yl 3-cyclopentylpropanoate
3,17|A-Hydroxy-1,3,5(10)-estratriene 17-cyclopentylpropionate
3,17beta-Hydroxy-1,3,5(10)-estratriene 17-cyclopentylpropionate
313-06-4
313D064
4-09-00-00047 (Beilstein Handbook Reference)
7E1DV054LO
AB00051984_02
AC-1672
AC1L1FJE
AC1L1SYP
AC1NWAM6
AC1Q62HT
ACN-032014
AKOS015895730
AKOS025401445
AN-14720
ANW-43364
API0002258
AS-13127
B-estradiol 17-cypionate
BC202634
BCP11930
beta-Estradiol 17-Cyclopentylpropionate
beta-Estradiol 17-cypionate
BRD-A91452556-001-02-4
BRD-A91452556-001-03-2
BRN 3171075
BSPBio_002002
C14640
C26H36O3
CAS-313-06-4
CCG-40221
CHEBI:34745
CHEBI:91954
CHEMBL1200973
CS-4691
Cyclopentanepropionic acid, 17-ester with estradiol
Cyclopentanepropionic acid, 3-hydroxyestra-1,3,5(10)-trien-17.beta.-yl ester
Cyclopentanepropionic acid, 3-hydroxyestra-1,3,5(10)-trien-17beta-yl ester
D04063
Dep-Estro
Depestro
depGynogen
Depo-Estradiol
Depo-estradiol (TN)
Depo-estradiol cyclopentylpropionate
Depoestra
Depoestradiol
Depoestradiol cypionate
Depofemin
DivK1c_000613
DSSTox_CID_2999
DSSTox_GSID_22999
DSSTox_RID_76824
DTXSID4022999
E. Ionate P.A
E. Ionate P.A.
E0875
EBD2157881
ECP (VAN)
EINECS 206-237-8
Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate
Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate
Estra-1,3,5(10)-triene-3,17-diol, (17beta)-, 17-cyclopentanepropanoate
Estra-1,3,5(10)-triene-3,17-diol(17b)-, 17-cyclopentanepropanoate
Estra-1,3,5(10)-triene-3,17beta-diol 17-(cyclopentanepropionate)
Estra-1,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate
Estra-1,5(10)-triene-3,17-diol, (17.beta.)-, 17-cyclopentanepropanoate
Estradep
Estradiol (cypionate)
estradiol 17 beta-cyclopentylpropionate
estradiol 17 beta-cypionate
Estradiol 17-cyclopentanepropionate
Estradiol 17-cyclopentylpropionate
Estradiol 17-cypionate
Estradiol 17.beta.-cyclopentanepropionate
Estradiol 17.beta.-cyclopentylpropionate
Estradiol 17.beta.-cylopentylpropionate
Estradiol 17.beta.-cypionate
Estradiol 17beta-cyclopentanepropionate
Estradiol 17beta-cyclopentylpropionate
Estradiol 17beta-cylopentylpropionate
Estradiol 17beta-cypionate
Estradiol cyclopentylpropionate
Estradiol cypionate (USP)
Estradiol cypionate [USAN]
Estradiol cypionate [USP]
Estradiol cypionate, United States Pharmacopeia (USP) Reference Standard
Estradiol, 17-cyclopentanepropionate
Estrapo
Estro-Depo
Femogen CYP
FT-0603375
H394
HMS1920M08
HMS2091D09
HMS2234K11
HMS501O15
HY-B1100
I06-0866
IDI1_000613
KBio1_000613
KBio2_001530
KBio2_004098
KBio2_006666
KBio3_001222
KBioGR_001179
KBioSS_001530
KS-5296
LS-64732
MCULE-7555922943
MFCD00056558
MLS000069763
MLS001074891
MolPort-003-666-182
MolPort-003-941-327
NCGC00013034-01
NCGC00166134-01
NCGC00166134-02
NCGC00166134-03
NCGC00178868-01
NCGC00255333-01
NCI60_002938
Neoginon Depositum
NINDS_000613
NSC 3354
NSC-3354
NSC-756761
NSC3354
NSC756761
Pertradiol
Pharmakon1600-01500283
s4046
SBI-0051371.P003
SCHEMBL20130822
SCHEMBL41551
SMR000058700
SPBio_001125
Spectrum_001050
SPECTRUM1500283
Spectrum2_001003
Spectrum3_000421
Spectrum4_000540
Spectrum5_000672
SR-05000001620
SR-05000001620-1
ST075189
SW219639-1
Tox21_110003
Tox21_112331
Tox21_112331_1
Tox21_301818
UNII-7E1DV054LO
UOACKFBJUYNSLK-XRKIENNPSA-N
VA10688
W-106910
ZINC3876078
ZINC3978001

US Patents and Regulatory Information for ESTRADIOL CYPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys ESTRADIOL CYPIONATE estradiol cypionate INJECTABLE;INJECTION 085620-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Harvard Business School
Express Scripts
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.